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Notch signaling is critical for cell fate decisions during development. Caenorhabditis elegans and vertebrate Notch
ligands are more diverse than classical Drosophila Notch ligands, suggesting possible functional complexities. Here, we
describe a developmental role in Notch signaling for OSM-11, which has been previously implicated in defecation and
osmotic resistance in C. elegans. We find that complete loss of OSM-11 causes defects in vulval precursor cell (VPC) fate
specification during vulval development consistent with decreased Notch signaling. OSM-11 is a secreted, diffusible
protein that, like previously described C. elegans Delta, Serrate, and LAG-2 (DSL) ligands, can interact with the lineage
defective-12 (LIN-12) Notch receptor extracellular domain. Additionally, OSM-11 and similar C. elegans proteins share a
common motif with Notch ligands from other species in a sequence defined here as the Delta and OSM-11 (DOS) motif.
osm-11 loss-of-function defects in vulval development are exacerbated by loss of other DOS-motif genes or by loss of
the Notch ligand DSL-1, suggesting that DOS-motif and DSL proteins act together to activate Notch signaling in vivo.
The mammalian DOS-motif protein Deltalike1 (DLK1) can substitute for OSM-11 in C. elegans development, suggesting
that DOS-motif function is conserved across species. We hypothesize that C. elegans OSM-11 and homologous proteins
act as coactivators for Notch receptors, allowing precise regulation of Notch receptor signaling in developmental
programs in both vertebrates and invertebrates.
Citation: Komatsu H, Chao MY, Larkins-Ford J, Corkins ME, Somers GA, et al. (2008) OSM-11 facilitates LIN-12 Notch signaling during Caenorhabditis elegans vulval
development. PLoS Biol 6(8): e196. doi:10.1371/journal.pbio.0060196
Introduction
The Notch signaling pathway is essential for cell fate
determination during embryogenesis and postembryonic
development in multicellular organisms. Classical Notch
signaling begins with activation of the Notch receptor by
transmembrane DSL ligands (Delta and Serrate in Drosophila
or LAG-2 [Lin and Glp-2] in C. elegans [1–3]) expressed on
adjacent cells, resulting in proteolytic cleavage of the Notch
receptor, internalization of the ligand-receptor complex, and
nuclear translocation of the Notch IC (intracellular) domain
[4–8]. In the nucleus, the Notch IC domain acts as a
transcriptional regulator together with a conserved tran-
scription factor called Su(H) (Suppressor of Hairless) in
Drosophila and LAG-1 [Lin and Glp-1] in C. elegans [9,10]. The
molecular mechanisms of Notch signaling are highly con-
served. Vertebrate homologs exist for each of these compo-
nents in the Notch signaling pathway, and mutations in Notch
signaling have been implicated in various developmental
disorders, including Alagille and CADASIL [11–14]
In C. elegans, the Notch receptor LIN-12 (Lineage defective-
12) plays critical roles in cell fate speciﬁcation in multiple
tissues. The roles of LIN-12 in two steps of vulval develop-
ment have been particularly well studied. First, LIN-12 is
required for cell fate speciﬁcation of an anchor cell (AC) and
a vulval uterine (VU) cell from the descendents of equipotent
precursor cells Z1 and Z4 during the L1 larval stage [15–18].
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PLoS BIOLOGYLoss of lin-12 signaling generally results in the speciﬁcation of
two ACs, whereas increased lin-12 signaling results in two VU
cells. The AC produces a diffusible epidermal growth factor
(EGF) signal that induces the primary (18) cell fate in P6.p, one
of six equipotent vulval precursor cells (VPCs) (reviewed in
[19]). Additionally, LIN-12 speciﬁes secondary (28) cell fates of
P5.p and P7.p, two VPCs adjacent to P6.p, by antagonizing
EGF signaling via lateral inhibition [17,20]. Loss of lin-12
signaling generally causes VPCs to take on 18 and tertiary (38)
fates, whereas strong lin-12 gain-of-function alleles cause
VPCs to take on 28 fates with consequent changes in the fates
of descendent cells that contribute to the adult vulva.
Canonical Notch receptor ligands are exempliﬁed by
Drosophila Delta, which contains a conserved N-terminal
DSL domain originally found in Delta, Serrate, and LAG-2
proteins [2,3,7,21,22]. The DSL domain is followed by a series
of EGF repeats and a transmembrane domain. The DSL
domain is critical for Notch receptor activation based on
tissue culture studies and genetic analysis [23,24], but Notch
ligand EGF repeats are also required for Notch receptor
activation [25,26]. Numerous Notch ligands containing DSL
domains have been identiﬁed in various organisms [23,27–32].
C. elegans LAG-2 is a classical Notch ligand containing a
canonical DSL domain and transmembrane domain and is
essential for LIN-12 activation in vivo in many contexts
[21,22].
Although key components in the Notch pathway were
identiﬁed decades ago in classical genetic studies in Drosophila
and C. elegans [33,34], additional proteins that play important
or redundant roles in Notch signaling have been identiﬁed
more recently. C. elegans anterior pharynx defective-1 (APX-1)
and DSL-1 are DSL domain–containing soluble proteins that
function redundantly with LAG-2 during vulval development
[35]. Noncanonical ligands for vertebrate Notch receptors
have been identiﬁed, including Delta/notch-like EGF repeat
containing protein (DNER), F3/contactin, and MAGP proteins
[36–40], but functional C. elegans homologs of these non-
canonical ligands have not been identiﬁed. Deltalike 1 (a.k.a.,
DLK1, fetal antigen 1 [FA1], ZOG, pG2, Preadipocyte Factor 1
[PREF1]) also encodes a putative soluble Notch ligand that
lacks a DSL domain [41–43,44]. DLK1 is a paternally
imprinted gene with diverse developmental roles. DLK1
knockout mice are growth retarded and obese with eye and
skeletal defects [45]. Overexpression of DLK1 due to polar
overdominance results in callipyge sheep with muscle over-
proliferation and decreased adipogenesis [45–47]. Although
Drosophila lacks a DLK1 homolog, ectopic expression of
mammalian DLK1 in Drosophila inhibits Notch signaling [48].
DLK1 has multiple mRNA isoforms; some transcripts are
translated as membrane-bound proteins with subsequent
proteolytic release of the EGF-repeat–containing extracellu-
lar domain, while others encode soluble secreted proteins
[42,43,49]. DLK1 EGF repeats bind Notch1 EGF repeats in
bacterial two-hybrid assays and inhibit activity of a Notch-
dependent reporter gene. However, DLK1 inhibits Notch
activation by previously described DSL Notch ligands in these
same studies [50]. Therefore, a role for DLK1 as a Notch
ligand is controversial, given the lack of a canonical DSL
domain and the inability of DLK1 to activate vertebrate
Notch receptors.
Here, we examine the secreted C. elegans protein, OSM-11.
A role for OSM-11 in osmotic sensitivity and defecation was
recently described, but the molecular function of these genes
was not elucidated in previous studies, and no homologous
proteins outside of nematodes were identiﬁed [51,52]. We
found that OSM-11 and related C. elegans proteins contain a
motif found only in known and putative Notch ligands,
including Serrate and DLK1. We examined the functional
role of osm-11 in development. We ﬁnd that osm-11 increases
lin-12 Notch receptor signaling during vulval cell fate
speciﬁcation. Our results suggest a model in which OSM-11
normally acts with C. elegans DSL ligands to activate Notch
receptor signaling in vivo.
Results
OSM-11 Is Required for Cell Fate Specification during
Vulval Development
We identiﬁed a deletion allele of osm-11 that removes all of
the predicted mature protein, osm-11(rt142). The majority of
animals lacking osm-11 had visibly misshapen vulva or
defective vulva based on retention of eggs (Figure 1A–1C).
A smaller fraction had an additional protrusion near the
normal position of the vulva. Vulval development was also
modestly perturbed by RNA interference (RNAi) knockdown
of osm-11 (16% defective, n ¼ 82), suggesting that osm-11
defects in vulval developmental were caused by loss of osm-11
function. Consistent with this hypothesis, osm-11 defects were
rescued by reintroduction of either genomic DNA containing
the entire osm-11 gene or the osm-11 cDNA expressed under
the control of 3.4 kb of upstream genomic DNA sequences 59
to the predicted osm-11 initiator methionine (described
below) and the unc-54 39 UTR. osm-11 loss of function also
caused non-vulval developmental defects, including mis-
shapen heads and anal protrusions (Figure 1D and 1E)
reminiscent of animals with decreased Notch signaling or
increased EGF signaling [9]. To determine the biochemical
role of OSM-11, a molecular and cellular analysis was ﬁrst
undertaken.
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Author Summary
The classic view of Notch receptor activation involves receptor
binding to transmembrane Notch ligands that contain a conserved
DSL (Delta, Serrate, and LAG-2) domain. Here, we find that the
Caenorhabditis elegans OSM-11 protein is a novel ligand of the well-
characterized Notch signal transduction pathway and plays a role in
cell fate specification during development. OSM-11 is a secreted,
diffusible protein whose loss decreases Notch signaling in vivo.
OSM-11 and related C. elegans proteins do not contain a DSL
domain, but contain a conserved motif we have named DOS (Delta
and OSM-11) that is also found in the extracellular domain of known
Notch ligands in organisms other than C. elegans. The functional
mammalian homolog of OSM-11 is the secreted protein Deltalike1
(Dlk1), also known as Preadipocyte Factor 1 (PREF1), which plays a
poorly defined role in Notch signaling regulating obesity and other
developmental decisions. This suggests that Notch ligands are split
into two complementary coligand families that act together to
regulate Notch signaling in developmental contexts. In addition to
regulating development, DOS ligands play roles in osmotic stress
and C. elegans behavior, suggesting previously unsuspected roles
for Notch signaling across species.osm-11 Encodes a Novel Protein with Similarity to Notch
Ligands
osm-11 corresponds to the C. elegans gene designated as
F11C7.5 at the National Center for Biotechnology (NCBI).
F11C7.5 is predicted to have two exons and one splice form,
which was conﬁrmed by cDNA sequencing (unpublished
data). OSM-11 and four similar predicted C. elegans proteins,
OSM-7 (T05D4.4), ZK507.4, K10G6.2, and K02F3.7, contain a
signal peptide for secretion and a potential cEGF-1 domain
[53] that is part of a conserved motif described below (Figure
2A). cEGF-1 domains contain a small amino acid and six
cysteine residues with characteristic spacing that forms three
disulﬁde bonds, and are found in extracellular proteins
including Notch receptors and ligands.
As standard similarity searching programs (i.e., BLAST)
failed to identify additional proteins similar to OSM-11
outside of helminthes, we undertook further bioinformatic
analysis, which revealed similarity between OSM-11 and
previously described Notch ligands. First, the predicted
sequences of C. elegans OSM-11, OSM-7, K10G6.2, ZK507.4,
and K02F3.7 proteins were aligned, which revealed conserved
amino acids in a common motif containing the putative
cEGF-1 domain and additional amino acids: C-X(3)-C-X(3,8)-
C-X(2,5)-C-[KVER]-C-X(10,12)-C-X(1,3)-P-X(6,9)-C-X(1,4)-W-
X(1,4)-C. Motif-based database searches revealed that all
proteins containing the new motif in Drosophila, zebraﬁsh,
mouse, and humans are either DSL-containing Notch ligands
or suspected Notch ligands. We named the motif DOS
because it is found in Delta and OSM-11-like proteins
(shaded in Figure 2) and designated the C. elegans genes
ZK507.4, K10G6.2, and K02F3.7 as dos-1, dos-2, and dos-3,
respectively. All ﬁve C. elegans DOS-motif proteins are likely
secreted based on the presence of a predicted N-terminal
signal peptide. However, OSM-11 and DOS-3 also have a
consensus proprotein convertase protease cleavage site and a
C-terminal transmembrane domain, suggesting that they may
be translated as transmembrane preproproteins prior to
proteolytic processing and release of a soluble DOS protein.
In known Notch ligands from Drosophila and vertebrates,
the DOS motif is always located immediately following the
DSL domain and overlapping the ﬁrst two EGF repeats. The
ﬁrst two EGF repeats of most Notch ligands differ from the
remaining EGF repeats [27] (this study, Figure 2C). The role
of these EGF repeats remains unclear, but several previous
studies suggest that these EGF repeats play roles in Notch
activation: they are required for the DSL domain of Jagged1
to bind to the mammalian Notch2 receptor in biochemical
studies [54]; perturbation of the second EGF repeat interferes
with Notch signaling in Drosophila [25]; and mutations in these
EGF repeats of human Jagged1 are associated with Alagille
syndrome [55]. The DOS motif may deﬁne a unique group of
EGF repeats and EGF-like repeats that have a distinct
functional role in Notch signaling.
Outside of helminthes, only three proteins were identiﬁed
with DOS motifs that are not canonical Notch ligands: C901,
DLK1, and EGFL9 (DLK2). These proteins have a signal
peptide sequence, and the DOS motif is located in the ﬁrst
two EGF repeats (Figure 2B). C901 is a predicted Drosophila
protein of unknown function containing a DSL domain and
multiple EGF repeats [56]; it is unclear whether C901 is a
transmembrane DSL domain protein. DLK1 and EGFlike 9
(EGFL9) are vertebrate proteins that contain EGF domains,
but lack DSL domains. EGFL9 is poorly characterized [57].
DLK1 has membrane-bound and secreted isoforms, and plays
diverse roles in normal development. Altered DLK1 expres-
sion causes developmental defects in mammals [42,45–47].
DLK1 EGF repeats containing the DOS motif bind to speciﬁc
Notch1 receptor EGF repeats in two-hybrid studies and in
tissue culture [50], but the role of DLK1 in Notch signaling
remains controversial because DLK1 lacks a DSL domain and
does not activate mammalian Notch receptors [42,45–47].
Given this controversy and given the limited homology
observed between OSM-11 and previously described canon-
ical Notch ligands, we turned to cellular, genetic, and
molecular tools in C. elegans to elucidate the role of OSM-11
in developmental signaling pathways.
Loss of osm-11 Perturbs Cell Fate Specification during
Vulval Development
We ﬁrst examined the role of osm-11 in speciﬁcation of the
AC. LIN-12 Notch function is required for cell fate
speciﬁcation of an AC and a VU cell from the equipotent
precursor cells Z1 and Z4 during the L1 larval stage [15–18].
Figure 1. OSM-11 Is Required for Normal Development
(A) Thirty-one percent of osm-11(lf) adult animals had overtly normal
vulva and did not retain eggs resembling control animals. (B) Fifty-seven
percent of osm-11(lf) animals inappropriately retained eggs and/or had a
single misshapen or protruding vulva (15% and 42%, respectively). (C)
Twelve percent of osm-11(lf) animals had an extra protrusion near the
normally positioned vulva. (D) osm-11(lf) animals had defects in head
morphology at low frequency (arrowhead). (E) Two thirds of osm-11(lf)
animals had a ventral protrusion behind the anus (arrowhead). n . 100
animals were scored.
doi:10.1371/journal.pbio.0060196.g001
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OSM-11 and LIN-12 Notch in DevelopmentLoss of lin-12 signaling results in the speciﬁcation of two ACs,
whereas increased lin-12 signaling results in two VU cells. AC
cells are readily quantiﬁed by examining expression of a lin-
3p::gfp reporter construct [58]. No alterations in lin-3p::gfp
were observed in osm-11(lf) animals compared to osm-11(þ)
animals (unpublished data; n¼92), suggesting that loss of osm-
11 does not alter AC cell fate speciﬁcation in otherwise
normal animals.
We next examined VPC speciﬁcation. After AC speciﬁca-
tion, the AC produces the diffusible EGF protein LIN-3 that is
required for induction of the 18 cell fate in P6.p, one of six
equipotent VPCs (reviewed in [19]). LIN-3 EGF acts via the
well-characterized Ras/MAPK (mitogen activated protein
kinase) pathway in VPCs. LIN-12 Notch function is required
to specify 28 cell fates of P5.p and P7.p, two VPCs adjacent to
P6.p, by antagonizing EGF signaling via lateral inhibition
[17,59]. Loss of EGF signaling eliminates 18 and 28 cell fates,
whereas aberrantly increased EGF/Ras/MAP kinase signaling
can cause all VPCs to adopt the 18 cell fate. By contrast, loss of
lin-12 Notch signaling causes all VPCs to take on 18 or 38 fates,
whereas strong Notch gain-of-function alleles cause all six
VPCs to take on 28 fates (Figure 3A). These VPC fate decisions
were assessed in osm-11(lf) animals and control animals at
speciﬁc larval stages using the previously described green
ﬂuorescent protein (GFP) reporter constructs egl-17p::gfp, lin-
11p::gfp, and lip-1p::gfp [60].
In L3 animals, egl-17p::gfp expression in P6.p is directly
dependent on EGF/Ras signaling, and egl-17 expression is
repressed in P5.p or P7.p by lateral inhibition via LIN-12
Notch signaling [60]. At the Pn.p stage, when cell fates are ﬁrst
established, egl-17p::gfp is only expressed in P6.p in wild-type
animals. We found appropriate egl-17p::gfp expression in the
P6.p cell (Figure 3B and 3C) of animals lacking osm-11, but
ectopic egl-17p::gfp expression in P5.p or P7.p in approx-
imately 10% of osm-11(lf) L3 animals. This ectopic egl-17p::gfp
expression suggests that in osm-11(lf) animals, P5.p and P7.p
secondary cell fates are not correctly established whereas the
18 cell fate choice of P6.p is unaffected. Later, at the L4 larval
stage, egl-17 expression normally is lost in wild-type animals
from P6.p descendents and observed only in 28 cell lineages,
i.e., in P5.p and P7.p descendants. In 71% of osm-11(lf) L4
animals, egl-17p::gfp expression in P5.p and/or P7.p descend-
ants was lost, consistent with loss of 28 cell fates (unpublished
data; n¼63). The aberrant egl-17p::gfp expression observed in
osm-11(lf) animals suggests that 18 and 28 cell fates are not
correctly speciﬁed in a fraction of osm-11(lf) animals,
consistent with decreased Notch signaling.
To determine whether secondary cell fates are lost in osm-
11(lf) animals, cell fate speciﬁcation was examined using lin-
11p::gfp and lip-1p::gfp reporter genes. lin-11p::gfp is expressed
exclusively in P5.p and P7.p vulval secondary lineages during
development [61,62] (98% of control wild-type late-L3
larvae), but lin-11p::gfp expression is lost in P5.p and/or P7.p
descendents in 67% of osm-11(lf) animals (Figure 3B and 3D).
Strikingly, 69% of osm-11(lf) adult animals had an overtly
defective vulva or retained eggs (Figure 1), which correlates
quantitatively with the loss of secondary cell fates observed
with altered lin-11p::gfp expression. Loss of lin-11 expression
at this stage suggests that secondary cell fates are either not
properly speciﬁed or not maintained in osm-11(lf) animals.
Secondary cell fate speciﬁcation can be more directly
assessed using lip-1p::gfp. In normal L3 animals, lip-1p::gfp
expression is up-regulated in P5.p and P7.p upon assumption
of secondary cell fate [63]. This up-regulation is directly
dependent on lin-12 Notch receptor signaling. However, in
35% of osm-11(lf) L3 animals, lip-1p::gfp was not up-regulated
in P5.p and/or P7.p (Figure 3B and 3E; vs. up-regulation in
98% of control animals). The loss of lip-1p::gfp and lin-11p::gfp
expression observed in osm-11(lf) animals is reminiscent of
changes observed when LIN-12 Notch signaling is decreased
and is not consistent with decreased EGF/Ras signaling.
osm-11 Is Expressed in VPCs and Hypodermal Cells
The functional signiﬁcance of the similarity of OSM-11 to
classic Notch ligands was unclear, particularly as OSM-11
lacks a DSL domain. To address the role of osm-11 in
development, the cellular and temporal pattern of osm-11
expression was examined to delineate its potential roles in
VPC fate speciﬁcation. A transcriptional GFP reporter (osm-
11p::gfp) was generated using the same upstream sequences
used for osm-11 cDNA rescue. In animals harboring this
transgene, GFP expression was observed in numerous
unidentiﬁed cells during embryonic development from the
comma stage onward (unpublished data). GFP expression was
observed in the VPCs during larval development, as well as
various hypodermal cells during larval stages (Figure 4). Using
polyclonal antisera raised against OSM-11 to stain wild-type
animals, we found that OSM-11 was expressed in the VPCs of
L3 larvae prior to and during cell fate speciﬁcation (Figure
4B). OSM-11 immunoreactivity was also observed in the seam
cells of L1 larvae and adult animals (Figure 4A and 4D). In
Figure 2. osm-11 Encodes a Protein with a Conserved Motif Found in Notch Ligands
(A) Top: OSM-11 genomic structure. The signal peptide is shaded black, and putative O-linked glycosylation sites are indicated by vertical lines. The DOS
motif is shaded blue; it overlaps the previously defined osmotic stress resistant (OSR) motif [52]. osm-11(rt142) removes all coding sequence after the
signal peptide; osm-11(rt68) converts W177 to a premature stop codon. Bottom: the DOS motif-containing sequences from C. elegans OSM-11, OSM-7,
DOS-1, DOS-2, and DOS-3 are aligned above the DOS motif consensus and the cEGF-1 consensus [53]. DOS-motif regions from mouse proteins and
known Drosophila Notch ligands are aligned under the cEGF-1 consensus. DOS-motif amino acids are shaded blue and previously described EGF repeats
are boxed. Asterisks (*) indicate cysteines in the conserved EGF-motif that are not found in the C. elegans DOS proteins. The DOS motif consensus is: C-
X(3)-C-X(3,8)-C-X(2,5)-C-[KVER]-C-X(10,12)-C-X(1,3)-P-X(6,9)-C-X(1,4)-W-X(1,4)-C. In the DOS motif consensus, b represents K, V, E, or R, and the dash (-)
indicates possible positions for proline in the DOS motif. In the cEGF-1 consensus, s represents a small amino acid [53].
(B) The position of the DOS motif in known or predicted C. elegans, Drosophila, and vertebrate Notch ligands. The DOS motif overlaps with the first two
EGF repeats of canonical Notch ligands and may define a unique subset of EGF repeats. The noncanonical Notch ligands DNER [40], F3/contactin [95],
and MAGP [36–40] do not contain a DOS motif (unpublished data).
(C) Similarity between DOS motifs, the first and second EGF repeats, and the third and fourth EGF repeats of Notch ligands. As noted by Lissemore and
Starmer [27], the first and second EGF repeats differ from the third and fourth EGF repeats. DOS-3 was not included in this alignment. Green indicates
the DOS motif of proteins that lack canonical EGF repeats; blue indicates the first and second EGF repeats of Notch ligands; red indicates the third and
fourth EGF repeats of Notch ligands; and magenta represents the C. elegans Notch ligands that lack DSL domains. See Materials and Methods for
accession numbers and other details.
doi:10.1371/journal.pbio.0060196.g002
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OSM-11 and LIN-12 Notch in Developmentadult animals, osm-11p::gfp was expressed only in hypodermal
seam cells in adult animals; hypodermal seam cell expression
in adult animals was also conﬁrmed with staining with OSM-
11 antisera (Figure 4D). The larval hypodermal expression
pattern of osm-11p::gfp is reminiscent of the osm-7p::gfp
expression pattern described previously, but osm-7p::gfp
expression in seam cells was not reported [52]. OSM-11
protein was also expressed in the developing uterus of L4
larvae (Figure 4B) and in the spermatheca (Figure 4D); the
LIN-12 Notch receptor plays a developmental role in these
tissues as well [64], but only OSM-11 expression in VPCs was
characterized further.
Initially, OSM-11 protein is detected at uniform levels in all
six equivalent VPCs. OSM-11 disappears from P5.p, P6.p, and
P7.p after 18 and 28 vulval cell fates are speciﬁed (based on up-
regulation of lip-1p::gfp; Figure 4B). OSM-11 was not detected
in VPC descendents. Previously described C. elegans DSL-
containing Notch ligands also have temporally regulated
expression patterns in the VPCs [35]. For example, based on
reporter construct analysis, soluble DSL-1 is only expressed
Figure 3. OSM-11 Loss Results in Cell Fate Specification Defects
(A) A simplified diagram of cell fate GFP marker expression in P5.p, P6.p, and P7.p. GFP expression is schematically shown in green. Note that
equivalence group members P3.p, P4.p, and P8.p are not shown. In wild-type animals, primary (18) cell fate markers are expressed in P6.p (top left),
whereas secondary (28) cell fate markers are normally expressed in P5.p and P7.p (top right). The first Pn.p division (by P5.p, P6.p, and P7.p) in mid-L3
larvae gives rise to Pn.px cells; the next divisions give rise to Pn.pxx cells in late-L3 larvae. Loss of Notch signaling does not stop 18 cell fate assumption
by P6.p, but results in inappropriate adoption of 18 cell fates by P5.p, P7.p, and their descendents. Loss of EGF/Ras signaling results in adoption of the
tertiary fate by P5.p and P7.p, and in some cases, P6.p, depending on the severity of the defect [96].
(B) Quantification of data from (C–E). p , 0.05 based on v
2 for each marker.
(C) Ten percent of L3 osm-11(lf) animals (right) ectopically express the 18 cell fate marker egl-17p::gfp in P5.p or P7.p, which normally adapt the 28 fate
(left).
(D) Sixty-seven percent of L3 osm-11(lf) animals lack expression of the 28 cell fate marker lin-11p::gfp in descendants of P5.p and/or P7.p.
(E) Thirty-five percent of L3 osm-11(lf) animals do not up-regulate expression of the 28 fate marker lip-1p::gfp in P5.p and/or P7.p. p , 0.05 based on v
2
for each marker. These data suggest osm-11(lf) animals have a loss of 28 cell fate specification consistent with loss of LIN-12 Notch signaling.
In (C–E), arrowheads indicate the positions of P5.p, P6.p, and P7.p.
doi:10.1371/journal.pbio.0060196.g003
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OSM-11 and LIN-12 Notch in DevelopmentFigure 4. osm-11 Is Expressed in VPCs and Other Tissues
(A) OSM-11 expression in seam cells of L1 larvae detected using a-OSM-11 antisera. The seam cells on the right side of an L1 animal are in focus; the
seam cells on the left side are visible and slightly out of focus. OSM-11 was not expressed in seam cells or hypoderm at other larval stages.
(B) OSM-11 expression in the developing uterus of L4 larvae. Left, a-OSM-11 antisera staining; right, visible light image.
(C) OSM-11 expression in vulval precursor cells (VPCs; arrowheads) in L3 larvae. The top panels show a-OSM-11 antisera staining of VPCs prior (top left)
and immediately after (top right) cell fate specification as assessed by lip-1p::gfp expression. An overlay of a-OSM-11 staining and lip-1p::gfp expression
shows that OSM-11 is concentrated on the apical surface of the VPCs (bottom right); this was confirmed using an ajm-1::gfp fusion (unpublished data).
(D) OSM-11 expression in seam cells and spermatheca in adult animals. An osm-11p::gfp reporter gene containing unc-54 39 UTR sequences is expressed
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OSM-11 and LIN-12 Notch in Developmentin P6.p and its descendents. OSM-11 expression in Pn.p cells
is consistent with a role for OSM-11 in initial cell fate
speciﬁcation.
Like LIN-12 Notch receptors, OSM-11 is primarily localized
to the apical side of VPCs (Figure 4B, inset). VPCs are
polarized epithelial cells; EGF and Notch signaling normally
occurs in separate cellular compartments. Lethal-23 (LET-23)
EGF receptors are localized to the basolateral surface of the
VPCs in close proximity to the AC [65], which is the source of
LIN-3 EGF. In contrast, LIN-12 receptors are primarily
localized to the apical surface of the VPCs. The apical
localization of OSM-11 in VPCs during cell fate speciﬁcation
suggests that OSM-11 is available to bind to LIN-12 receptors
in VPCs at the time of cell fate speciﬁcation.
Osmotic Stress Response Does Not Alter Vulval Cell Fate
Specification
osm-11 and osm-7 were previously implicated in osmotic
stress resistance [51,52]. Pre-exposure of wild-type C. elegans
to high external osmolarity is sufﬁcient to induce osmotic
resistance. Loss of either osm-7 or osm-11 allows animals to
survive high external osmolarity without pre-exposure. The
cellular and molecular mechanisms underlying osmotic stress
resistance in either scenario are poorly understood, but up-
regulation of gpdh-1 and increased levels of the osmolyte
glycerol have been implicated [51,52]. As loss of osm-11
increases glycerol levels and increased osmolyte levels can
alter protein folding, osm-11 could act indirectly to decrease
Notch receptor signaling in VPC fate speciﬁcation. Alter-
natively, OSM-11 might act directly upon Notch receptors
involved in VPC fate speciﬁcation. Our experimental results
below favor the latter model; the role of OSM-11 in vulval cell
fate speciﬁcation is distinct from the role of OSM-11 in
osmotic stress.
If osmotic stress indirectly decreases Notch receptor
signaling, then vulval development should be altered by
osmotic stress and altered by genetic backgrounds with
increased osmotic stress resistance. We ﬁrst tested this
hypothesis by raising wild-type animals under previously
deﬁned osmotic stress conditions: 200 and 400 mM NaCl.
Rearing under osmotic stress conditions did not alter vulval
morphology, and the cellular expression patterns of vulval
cell lineage markers (lip-1p::gfp, egl-17p::gfp,o rlin-11p::gfp)i n
VPCs were unchanged (unpublished data). We also examined
genetic backgrounds previously implicated in osmotic stress
resistance; neither osr-1 nor daf-2 animals have altered vulval
morphology [66–68]. In addition, we considered the possi-
bility that OSM-11 expression in the vulval cell precursors
might be altered by osmotic stress. We found that rearing
under osmotic stress conditions (400 mM NaCl) did not alter
OSM-11 protein levels in VPCs (unpublished data). Com-
bined, all of these data suggest that osmotic stress does not
itself regulate vulval development. Instead, these data suggest
that the roles of osm-11 in vulval development and osmotic
stress resistance are independent.
OSM-11 Is a Secreted Protein
Because the predicted peptide sequence of OSM-11
contains a signal peptide, we tested whether OSM-11 is a
secreted protein. When an osm-11 cDNA was expressed in
Drosophila S2 tissue culture cells, OSM-11 protein accumulates
in the media and not in cells (Figure 5A), consistent with
OSM-11 acting in vivo as a soluble protein in the extracellular
milieu. The ability of OSM-11 to diffuse and act as a soluble
factor in vivo was tested by ectopically expressing OSM-11 in
non-VPC cells in osm-11(lf) animals. osm-11 cDNA was fused to
osm-10 or glr-1 promoter fragments that drive expression in
nonoverlapping subsets of neurons throughout larval devel-
opment. The osm-10 promoter drives expression in four
classes of sensory neurons located exclusively in the head and
tail [69]. The glr-1 promoter drives expression in 17 other
classes of neurons (distinct from osm-10–expressing neurons)
Figure 5. osm-11 Encodes a Secreted Protein Required for Vulval Development
(A) Western blot of conditioned media from Drosophila S2 cells containing an OSM-11 cDNA expression construct or empty vector. OSM-11 was not
detected in cell lysates (unpublished data). The molecular weight of mature OSM-11 was predicted at 18.9 kDa; the detected protein migrated at 20.7
kDa (arrowhead). OSM-11 may be O-linked glycosylated (see Figure 2).
(B) Transgenic rescue of osm-11(lf) vulval defects. osm-11(lf) animals harboring transgenes with empty expression vectors were indistinguishable from
nontransgenic osm-11(lf) animals (n ¼ 129 animals, 5 transgenic lines) and were used as controls. Multiple transgenic lines were scored for all rescue
experiments; data are reported as mean 6 standard error of the mean (S.E.M.) In addition to a genomic osm-11 construct, expression of the osm-11
cDNA using the following promoters also significantly rescued osm-11(lf) vulval defects: osm-11p, hsp-16p (ubiquitous expression; 79% normal vulval;
unpublished data), wrt-6p (hypodermal), osm-10p (sensory neurons), and glr-1p (nonoverlapping set of neurons vs. osm-10p). In addition, heterologous
expression of mammalian DLK1 driven by the hsp-16 promoter also significantly rescued osm-11(lf) vulval phenotypes. n . 52 animals for each
transgene, p , 0.05 by v
2.
doi:10.1371/journal.pbio.0060196.g005
in adult seam cells (left); a-OSM-11 antisera was used to confirm seam cell and spermatheca expression (right). No OSM-11 was detected in neurons of
larvae or adult animals (unpublished data); embryonic expression was not characterized.
In (A–D), the scale bar represents 10 lm.
doi:10.1371/journal.pbio.0060196.g004
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expressing neurons have processes in the ventral nerve cord
near the VPCs. We found that neuronal expression of the osm-
11 cDNA signiﬁcantly rescued osm-11 vulval defects to levels
comparable with osm-11 promoter-driven cDNA rescue
(Figure 5B). Consistent with these results, hypodermal
expression of osm-11 cDNA using the wrt-6 promoter [72]
also rescued osm-11 defects, albeit at a lower level. We
conclude that osm-11 can act nonautonomously and that
soluble OSM-11 can diffuse in vivo. Although OSM-11
expressed in VPCs may be sufﬁcient for normal vulval
development, OSM-11 can probably function at a distance
in some contexts like soluble DSL ligands in C. elegans [35].
osm-11 Acts Upstream of lin-12 Notch Receptor Activation
to Increase Signaling
The phenotypic defects caused by loss of osm-11 might be
due to OSM-11 action upon previously identiﬁed molecular
pathways that regulate cell fate speciﬁcation in vulval
development. We tested the sensitivity of the EGF, Notch,
and synthetic multivulva (SynMuv) VPC fate speciﬁcation
pathways to osm-11 levels by RNAi knockdown of osm-11 in
mutants that have been previously used as sensitized back-
grounds for each pathway: lin-12(n137n460csgf) Notch (see
below), let-23(sa62gf) EGF receptor, let-60(n1046gf) Ras, or lin-
15(n765tslf) SynMuv [73–78]. osm-11(RNAi) had the most effect
in animals with compromised lin-12 Notch signaling (27%
change in multivulva (Muv) of lin-12(n137n460);osm-11(RNAi)
at 20 8C versus less than 9% change in other backgrounds, p ,
0.05, n . 50 each). Although it is difﬁcult to assess the relative
sensitivity of these various genetic backgrounds, these results
suggested that Notch signaling might be particularly sensitive
to OSM-11 levels and that osm-11 might modulate lin-12
signaling during vulval development.
To more accurately assess the possible role of osm-11 in lin-
12 Notch signaling in vivo, we undertook genetic studies
using the osm-11(lf) null allele and previously described lin-12
alleles. lin-12(n137) is a ligand-independent dominant gain of
function (gf) allele, whereas lin-12(n137n460) is a recessive,
cold-sensitive gain-of-function allele (csgf). Both cause multi-
ple ectopic vulvae (Muv) due to secondary cell speciﬁcation
defects [79,80]. If OSM-11 normally functions to increase
Notch signaling, then loss of OSM-11 should decrease LIN-12
Notch signaling. We found that osm-11(lf) partially suppressed
the Muv defect of lin-12(csgf) at the restrictive temperature,
consistent with OSM-11 normally increasing lin-12 signaling
(Figure 6C and 6D). However, osm-11(lf) did not suppress the
stronger lin-12(gf) allele (Figure 6E and 6F). Since lin-
12(n137gf) is thought to activate lin-12 signaling in a ligand-
independent manner, the inability of osm-11(lf) to suppress
lin-12(gf) is consistent with osm-11 acting before or during
ligand activation of LIN-12.
If osm-11 normally acts before or during ligand activation
of LIN-12, then lin-12(lf) should be epistatic to osm-11(lf). lin-
12(lf) animals are sterile and have a single large protruding
vulva [80], a phenotype that is easily distinguishable from the
misshapen vulva of osm-11(lf) animals (compare Figure 1B and
1C with Figure 6B). lin-12(lf);osm-11(lf) double-mutant animals
were indistinguishable from lin-12(lf) animals, suggesting that
osm-11 acts upstream of lin-12 Notch (Figure 6A and 6B).
Combined, these results suggest that OSM-11 normally
increases LIN-12 Notch signaling in vivo and acts before or
during receptor activation.
OSM-11 Functions with Other DOS Proteins in
Development
Five C. elegans genes encode putative secreted DOS-motif
proteins: osm-11, osm-7, dos-1, dos-2 [51,52], and dos-3. Loss-of-
function alleles are not currently available for dos-2 and dos-3,
but osm-7(tm2256) and dos-1(ok2398) are deletion alleles
generated by the C. elegans gene knockout consortia and are
likely strong loss-of-function (lf) or null alleles. osm-
Figure 6. osm-11 Normally Increases Notch Signaling during Vulval Development
(A and B) lin-12(lf) is epistatic to osm-11(lf). lin-12(lf) is the null allele n941; animals carrying this allele have a protruding vulva (pVul; [A]) that is distinct
from the defective vulva seen in osm-11(lf) animals (see Figure 1). lin-12(lf);osm-11(lf) animals were indistinguishable from lin-12(lf) animals (B).
(C and D) osm-11(lf) suppresses lin-12(csgf) at 15 8C. lin-12(csgf) is n137n460, a recessive cold-sensitive gain-of-function allele; animals carrying this
mutation have multiple pseudovulvae (Muv; [C]). lin-12(csgf);osm-11(lf) animals were significantly less Muv (nonMuv) than lin-12(csgf) animals ([D]; p ,
0.05).
(E and F) osm-11(lf) does not suppress lin-12(gf). lin-12(gf) is n137, a dominant gain-of-function allele that is ligand independent; animals carrying this
mutation are Muv (E). lin-12(gf);osm-11(lf) animals were indistinguishable from lin-12(gf) animals (F). n . 50 animals were scored for each genotype.
doi:10.1371/journal.pbio.0060196.g006
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OSM-11 and LIN-12 Notch in DevelopmentFigure 7. OSM-11 Acts Synergistically with DSL Ligands and Other DOS Proteins
In (A and B), phenotypes were scored as in Figure 1. (A) Genetic interactions between osm-11 and DOS-motif genes osm-7 and dos-1 (ZK507.4). dos-1(lf)
and osm-7(lf) are both presumptive null alleles, and animals harboring these alleles had normal vulvas. dos-1(lf);osm-11(lf) and osm-7(lf);osm-11(lf)
animals had significantly more severe defects than osm-11(lf) animals (p , 0.005, v
2 test). Mutant alleles of dos-2 (K10G6.2) and dos-3 (K02F3.7) are not
currently available.
(B) Genetic interactions between osm-11 and DSL-domain genes lag-2 and dsl-1. lag-2(dn) is the dominant negative allele sa37; dsl-1(lf) is ok810 and is a
presumptive null allele. lag-2(dn) and dsl-1(lf) animals had few or no vulval defects. lag-2(dn);osm-11(lf) and dsl-1(lf);osm-11(lf) animals had significantly
more-severe defects that osm-11(lf) animals (p , 0.005, v
2 test).
(C) Vulval precursor cell (VPC) fate analysis for osm-11 and dsl-1. Arrowheads indicate the positions of P5.p, P6.p, and P7.p. Secondary (28) cell fates were
scored as in Figure 3 using lip-1p::GFP as illustrated (right). dsl-1;osm-11 double-mutant animals had significantly more severe 28 fate specification defects
compared to either single mutant alone (p , 0.005 by v
2). n   48 for each genotype in all panels.
doi:10.1371/journal.pbio.0060196.g007
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avoid high osmolarity, similar to previously published osm-7
alleles [51,52].
To determine whether DOS-motif proteins have over-
lapping functions, we tested whether mutants defective in
more than one DOS-motif protein had stronger vulval
defects. Loss of either osm-7 or dos-1 alone had little or no
overt effect on vulval morphology. However, loss of dos-1 or
osm-7 increased the percentage of osm-11(lf) animals with
multiple vulval protrusions (Figure 7A). This result is
consistent with multiple DOS-motif proteins acting in vulval
development.
OSM-11 Functions with DSL Ligands to Increase Notch
Signaling
Classical C. elegans Notch DSL ligands are expressed in
VPCs and function redundantly during cell speciﬁcation [35].
Accordingly, DOS-motif proteins may also function redun-
dantly in VPC speciﬁcation. One might expect that DSL-
domain proteins and DOS-motif proteins would act together
to activate Notch signaling. Therefore, loss of a DSL protein
should exacerbate osm-11 developmental defects. dsl-1 enc-
odes a DSL domain-containing ligand which acts redundantly
with two other DSL proteins to activate LIN-12 Notch
signaling during vulval development [35]. Because of this
redundancy, the dsl-1(ok810lf) null allele does not itself cause
vulval defects [35]. However, dsl-1(lf);osm-11(lf) double mutants
had modestly increased phenotypic defects in vulval mor-
phology compared to osm-11 single mutants. osm-11(lf) vulval
defects were similarly enhanced by lag-2(lf), which encodes a
DSL ligand (Figure 7B). To more precisely assess interactions
between osm-11 and dsl-1, the expression of lip-1p::gfp in dsl-
1(lf);osm-11(lf) animals was assessed during VPC fate speciﬁ-
cation. Eighty-six percent of the double-mutant animals
lacked lip-1p::gfp up-regulation in either one or both
presumptive secondary VPCs, indicating a substantial syner-
gistic loss of secondary fate speciﬁcation (Figure 7C). This
result is consistent with DOS-motif (i.e., OSM-11) and DSL-
domain proteins working together to increase LIN-12 Notch
signaling.
OSM-11 Interacts with LIN-12 Extracellular EGF Repeats in
a Yeast Two-Hybrid Assay
The cellular nonautonomy of osm-11, the similarity of OSM-
11 to Notch ligands, the expression pattern of OSM-11, and
the genetic implication that osm-11 functions before or
during LIN-12 Notch activation in VPC fate speciﬁcation
collectively suggest that OSM-11 may function as a LIN-12
Notch ligand. We tested the hypothesis that OSM-11 directly
interacts with the LIN-12 extracellular domain. Previous
studies demonstrated that Drosophila and vertebrate DSL
ligands bind to the extracellular EGF repeats of Notch
receptors. In preliminary studies, we were unable to
demonstrate direct binding between OSM-11 and LIN-12
biochemically using a heterologous expression system (un-
published data). Therefore, we turned to the yeast two-hybrid
assay to test whether OSM-11 can interact with LIN-12
extracellular EGF repeats. Conventional wisdom suggests that
the yeast two-hybrid system is not suitable for testing
extracellular protein–protein interactions, especially for
domains rich in disulﬁde bridges (e.g., EGF repeats). However,
two-hybrid interactions have been demonstrated between
Notch receptors and ligand pairs in other species for which
biochemical interactions have been previously validated
[38,39,50], as well as for numerous other extracellular
proteins [81–86].
To validate our yeast two-hybrid approach, we ﬁrst
conﬁrmed that the extracellular domain of LAG-2 [23] and
the soluble DSL-domain LIN-12 ligand DSL-1 [35] interact
with LIN-12 extracellular EGF repeats 1 through 6 in the two-
hybrid assay (Figure 8). To the best of our knowledge, this is
the ﬁrst in vitro evidence that C. elegans DSL ligands may bind
directly to LIN-12 Notch. As a negative control and to
conﬁrm speciﬁcity of the two-hybrid assay, we showed that
the unrelated C. elegans ligands LIN-3 (an EGF homolog) and
egg laying defective-17 (EGL-17) (an FGF homolog) do not
interact with LIN-12 extracellular EGF repeats (Figure 8). The
LAG-2 and DSL-1 interactions with LIN-12 in the two-hybrid
assay are consistent with previous genetic studies in C. elegans
Figure 8. OSM-11 and C. elegans DSL Ligands Interact with LIN-12 Notch
Extracellular Domain EGF Repeats in the Two-Hybrid System
DSL-1, OSM-11, LAG-2 extracellular domain (LAG-2Ex), EGL-17, or LIN-3
was fused to the GAL4 DNA binding domain (DB); the first six LIN-12 EGF
repeats were fused to the GAL4 activation domain (AD). Pairwise
interactions were tested with the yeast two-hybrid assay; positive
interactions are indicated by blue staining. Both Notch DSL ligands and
OSM-11 interacted with LIN-12 EGF repeats, whereas no interaction of
LIN-3 EGF or EGL-17 FGF with LIN-12 Notch receptor EGF repeats was
detected. LIN-12::DB fusion proteins exhibited strong self-activation
(unpublished data); therefore, reciprocal fusions were not tested.
Interaction controls are: (1) empty vectors; (2) DB-pRb and AD-E2F; (3)
DB-Fos and AD-Jun; (4) Gal4p and pPC86; and (5) DB-DP1 and AD-E2F1.
doi:10.1371/journal.pbio.0060196.g008
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interactions in other systems. Ligand-receptor interactions
were only assayed using LIN-12 fused to the GAL4 activation
domain (AD) as LIN-12 EGF fusion to the DNA-binding
domain resulted in strong self-activation in the presence of
AD empty vector (unpublished data).
We found that OSM-11 also interacted with LIN-12
extracellular EGF repeats 1 through 6 (Figure 8); OSM-11
did not interact with DSL-1 or LAG-2 ligands. We also
conﬁrmed previous studies [50] in which murine DLK1 EGF
repeats 1 and 2 containing the DOS motif interacted
speciﬁcally with murine Notch1 EGF repeats 12 and 13 in
the same two-hybrid assay format (unpublished data). The
two-hybrid interaction does not necessarily demonstrate that
OSM-11 and LIN-12 interact in vivo; however, combined with
the genetic interactions, the apical expression pattern of
OSM-11 in VPCs, and previous studies of DLK1/Notch
interactions, we favor a simple model in which OSM-11
binds directly to LIN-12 Notch EGF repeats. Further
biochemical studies will be required to demonstrate DOS-
motif protein direct interactions with Notch receptors.
The Mammalian DOS-Motif Protein DLK1 Can Substitute
for OSM-11
Our results suggest that the DOS-motif protein OSM-11
may act as a soluble LIN-12 ligand in C. elegans. This raises the
issue of whether other DOS-motif proteins such as DLK1,
which has been implicated in Notch signaling in mammalian
cells, also acts as soluble Notch ligands. The precise role of
DLK1 in mammalian Notch signaling is controversial. To
address the function of mammalian DLK1 in Notch signaling,
we tested the ability of DLK1 to functionally substitute for
OSM-11 in vivo in C. elegans. We found that expression of a
soluble, mature DLK1 protein isoform named FA1 [43] in osm-
11(lf) animals signiﬁcantly rescued vulval development,
consistent with DLK1 protein increasing LIN-12 signaling
(Figure 5D). This result suggests that the function of C. elegans
DOS-motif proteins is to increase Notch receptor signaling
and that the molecular mechanism may be conserved across
species.
Discussion
The data presented herein demonstrate that osm-11 is
required for normal vulval development in C. elegans. osm-11
encodes a novel cEGF-1 protein that is similar to, but distinct
from, previously characterized Notch ligands in vertebrates
[53]. OSM-11 contains a previously unidentiﬁed protein motif
that we have named DOS (Delta and OSM-11) overlapping the
EGF motifs. The DOS motif is conserved across species and
found in canonical Notch ligands. OSM-11 is a secreted
protein that is expressed in VPCs during cell fate speciﬁca-
tion. Genetic analysis suggests that OSM-11 acts upstream of
LIN-12 and that OSM-11 normally increases LIN-12 Notch
signaling in vivo. Two-hybrid data and expression on the VPC
apical surfaces suggest that OSM-11 may directly bind to the
LIN-12 extracellular domain, although additional biochem-
ical studies will be required to further conﬁrm this. Finally,
we demonstrated that the mammalian DOS-motif protein
DLK1 can partially substitute for OSM-11 in C. elegans vulval
development, suggesting that DOS-motif protein function is
conserved across species.
Our data suggest a model wherein OSM-11 and C. elegans
DSL ligands act together to activate Notch receptors,
potentially as a C. elegans bipartite ligand that is functionally
equivalent to Drosophila Delta or mammalian Jagged1 (Figure
9). Previously described C. elegans DSL ligands such as LAG-2
lack a DOS motif; C. elegans DSL ligands, such as LAG-2, and
Figure 9. Model: C. elegans DSL and DOS Proteins May Act as Ligands for Notch Receptors
Canonical Notch ligands in Drosophila contain both DSL domains and DOS motifs as do some vertebrate Notch ligands (e.g., Delta). However, classical
Notch ligands from C. elegans and several vertebrate Notch ligands contain a DSL domain, but lack DOS-motif EGF repeats (e.g., LAG-2 or DLL3). The C.
elegans proteins characterized in this study (e.g., OSM-11) and the two presumptive vertebrate ligands DLK1 and EGFL9/DLK2 lack DSL domains, but
contain DOS motifs. In the simplest model, both a DOS motif and DSL domain are required for coordinated Notch receptor activation. These could act in
cis in canonical Notch receptors like Drosophila Delta or in trans in the case of LAG-2 and OSM-11. Overexpression of a ‘‘DOS-only’’ or a ‘‘DSL-only’’
ligand may inhibit Notch receptor activation by competition with canonical ligands containing both a DSL domain and a DOS motif, such as Jagged1 or
Delta. This model is consistent with osm-11(lf) animals having phenotypic defects usually associated with Notch loss of function. We do not exclude
other possible scenarios; see Discussion for details.
doi:10.1371/journal.pbio.0060196.g009
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to activate LIN-12 Notch receptor signaling in vivo. Classical
studies in C. elegans have shown that expression of the APX-1
N-terminus (which contains the DSL domain) is sufﬁcient to
activate Notch signaling; however, this is not inconsistent
with our model because endogenous DOS-motif proteins
were present [23]. Our model is also consistent with previous
biochemical and genetic studies that showed the ﬁrst two EGF
repeats of Jagged1 and Delta are critical for high-afﬁnity
DSL-domain binding to mammalian Notch receptors and
Notch receptor activation [25,54].
Bipartite or heteromeric ligands are relatively rare
compared to heteromeric receptors. To our knowledge,
bipartite ligands have only been described previously in the
immune system. The binding of antigen to complement
fragment creates, in effect, a bipartite ligand for antigen
receptor as does the binding of an antigenic peptide to a
compatible major histocompatibility complex (MHC) subunit.
Additionally, and perhaps more pertinently, heterodimeric
cytokines have been described in the immune system that
bind to cytokine receptors [87]; for example, the interleukin-
12 (IL-12) cytokine is composed of p40 and p35, whereas the
IL-23 is composed of p40 and p19. Although bipartite ligands
are unusual, they are not unprecedented.
Previous studies have shown that the mammalian DOS-
motif protein DLK1 acts as a competitive antagonist of ligand
Jagged1, a canonical ligand that contains both a DSL domain
and DOS motif [50]. Therefore, a plausible alternative model
(which takes into account DLK1 antagonism of Jagged1) is
that DOS-motif proteins bind to Notch receptors, but
function as antagonists of DSL-domain Notch ligands in all
species. DOS proteins such as OSM-11 might play a role in
maintaining C. elegans Notch receptor levels or localization,
although LIN-12 Notch expression is unaltered in animals
lacking osm-11. Based on our data, we instead favor the
simpler model of DOS-motif proteins as activators of Notch
receptors acting with DSL proteins. In an independent
behavioral analysis (M. Chao, J. Larkins-Ford, T. Tucey, H.
Komatsu, and H. Dionne, et al., unpublished data), we also
found that OSM-11 activates both LIN-12 and germline
proliferation defective-1 (GLP-1) in the adult nervous system
to regulate behavior. We speculate that if DLK1 was
coexpressed in mammalian systems with a C. elegans DSL-
only ligand, then Notch signaling might be increased.
Mammalian Delta like 3 (DLL3) and DLL4 ligands contain
DSL domains, but not DOS motifs. Biochemical studies have
shown that DLL3 inhibits Notch signaling and DLL4 increases
Notch signaling in various contexts. It would be useful to
examine Notch activation when DLK1 and DLL3 are coex-
pressed. Clearly, biochemical analyses addressing the role of
DOS motifs and DSL domains in Notch receptor activation
will be required to discriminate between these two models
and to determine the relative contributions of DSL and DOS-
motif proteins to Notch signaling.
C. elegans DSL ligands function redundantly, activating LIN-
12 Notch during vulval development; loss of any one DSL
ligand gene causes mild or no overt defects [35]. Similarly,
loss of osm-11 alone caused only mild defects in vulval
morphogenesis, whereas loss of more than one DOS-motif
gene resulted in more-severe vulval defects. Like DSL ligands,
DOS-motif proteins function semiredundantly to increase
Notch signaling in vivo. In addition, genetic analysis suggests
that DOS-motif proteins and DSL proteins may act together
to regulate Notch receptors. It is possible that Notch receptor
activation by ligands during VPC development is robust due
to this redundancy. This multifactorial system for regulation
of Notch receptors might allow use of individual soluble DOS
or DSL proteins in other cell–cell signaling events in other
tissues simultaneously.
Deﬁning a role herein for osm-7 and osm-11 in Notch
signaling suggests that this pathway also plays a previously
unsuspected role in osmotic stress response. C. elegans can
adapt to increased environmental osmolarity; animals ex-
posed to moderate osmotic stress increase internal osmolyte
levels and have altered behavior reminiscent of animals
lacking osm-11 or osm-7 [51,52]. A role for Notch signaling in
osmotic stress has not been reported in any species. The
developmental role of Notch signaling in vulval cell fate
speciﬁcation is distinct from the role in osmotic stress
response based on data presented here. Further studies will
be required to determine whether diffusible DOS proteins act
as humoral factors to regulate Notch signaling in multiple
tissues to coordinate physiological and behavioral adaptation
to osmotic stress.
The diversity of Notch receptors and ligands is remarkable.
C. elegans has two Notch receptors (lin-12 and glp-1), ten DSL
domain proteins that lack DOS motifs [35] and ﬁve DOS-
motif proteins without DSL domains (this study). Mammals
have four Notch receptors, multiple DSL ligands, and two
presumptive DOS-motif–only ligands: DLK1 and EGFL9/
DLK2. Additional proteins have been suggested to act as
Notch ligands in vertebrates [36–40], but invertebrate
homologs have not been identiﬁed. At least one DSL domain
Notch ligand in each vertebrate species we examined (zebra-
ﬁsh, humans, and mice) lacks the conserved DOS motif; these
proteins are potentially analogous to C. elegans DSL domain
ligands (e.g., LAG-2) that also lack DOS motifs. Soluble Notch
ligands are now predicted in all of these species based on this
and previous studies. In contrast, Drosophila has only one
Notch receptor, and the two previously characterized trans-
membrane Drosophila Notch ligands contain both DSL
domains and DOS motifs. This heterogeneity of Notch
ligands and receptors indicates that the functional relation-
ship between Notch receptors and ligands is highly complex,
allowing precise regulation of signaling.
Materials and Methods
Characterization of osm-11. The osm-11(rt68) mutant allele was
identiﬁed in a classical genetic screen based on defective chemo-
sensory response and temporarily designated sel-14 (suppressor/enhancer
of lin-12-14). The rt68 mutation was mapped to the predicted C. elegans
gene F11C7.5 and mutates W177 to a premature stop codon, resulting
in premature truncation of translation near the end of the DOS
motif. Recent published studies and our analysis herein conﬁrmed
that sel-14(rt68) is an allele of osm-11 and has the same amino acid
change as the previously identiﬁed allele osm-11(n1604) [52,88];
therefore, we refer to this gene as osm-11. The deletion allele osm-
11(rt142) was identiﬁed by PCR-based screening of a frozen ethyl-
methane sulfonate (EMS)-mutagenized library of C. elegans strains
[89]. The rt68 and rt142 alleles had similar phenotypic defects, but the
rt142 deletion allele was more severe. Both osm-11 alleles are recessive.
osm-11(rt142) is likely a complete loss-of-function (lf) allele and was
used exclusively herein. RNAi of osm-11 was performed by raising N2
animals on a lawn of bacteria expressing osm-11 double-stranded
(dsRNA). Other than morphological defects, vulva perturbations, and
consequent egg-laying defects, osm-11(rt142lf) animals are overtly
normal in locomotion, male mating, and reproduction, although
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wild-type animals. osm-11 animals frequently had ventral protrusions
posterior to the anus. Postanal swelling is frequently associated with
bacterial infections, but swelling occurs in uncontaminated osm-11
animals raised on standard OP50 bacteria. Gonad morphology was
subtly altered in osm-11 animals but was not further characterized
here. osm-11 loss of function alters glp-1 germline proliferation
defects (M. Chao, J. Larkins-Ford, T. Tucey, H. Komatsu, and H.
Dionne, et al, unpublished data). osm-11(rt142) animals are osmotic
stress resistant and are motile on 500 mM NaCl NGM plates,
consistent with previously published phenotypes of osm-11(n1604)
[52].
Strains and genetics. Gain-of-function lin-12 alleles used herein
included the constitutive dominant allele lin-12(n137gf) and the cold-
sensitive recessive gain-of-function allele lin-12(n137n460gfcs). Results
from homozygous lin-12(n137) and heterozygote lin-12(n137)/þ ani-
mals were pooled in Figure 6. The lin-12(n941) null allele was
maintained by balancing over either qC1 containing qIs26 [rol-6(d), lag-
2::gfp] or over unc-32(e189). Genetic epistasis of osm-11 with lin-
12(n941) was assessed using homozygous lin-12(lf) progeny of lin-12(lf)/
unc-32(e189) animals. A fraction of animals were singled as larvae and
subsequently scored for vulval morphology and genotype. lin-12(n941)
animals were always sterile regardless of osm-11 status; lin-12(n941)/
unc-32 animals lacked protruding vulva and yielded unc-32 progeny
regardless of osm-11 status.
The deletion alleles osm-7(tm2256) and dos-1(ok2398) were generated
by the C. elegans gene knockout consortia. The osm-7(tm2256) deletion
removes the ﬁrst part of the DOS motif and eliminates an exon splice
site, resulting in a predicted frame shift after amino acid 200 with
premature truncation after translation of 21 amino acids. The dos-
1(ok2398) allele is a 1.7-kb deletion that removes the initiator
methionine and the ﬁrst ﬁve exons, including the DOS motif. All
deletion alleles were backcrossed at least four times prior to analysis.
Double-mutant analysis in Figure 7 was performed in an ayIs4 genetic
background. Other alleles used in this study include lag-2(sa37) and
dsl-1(ok810).
Analysis of VPC fate speciﬁcation. Pn.p cells and descendents were
identiﬁed by differential interference contrast (DIC) imaging on a
Zeiss Axioskop2. The transgenic arrays used for VPC fate analysis
were: ayIs4 [egl-17p::gfp], syIs107 [lin-3p::gfp], oyIs31 [lin-11p::gfp], and
zhIs4 [lip-1p::gfp] [58,60,63,90]. Animals were scored at the Pn.p and
Pn.px stages for egl-17p::gfp and lip-1p::gfp, but only at the Pn.pxx stage
for lin-11p::gfp. Rearing on 400 mM NaCl NGM plates dramatically
slows growth and results in partially penetrant embryonic and larval
lethality. In less than 10% of all animals raised under these
conditions, Pn.p cells/descendents could not be identiﬁed by DIC;
these animals were excluded from the analysis. oyIs31 animals were
nonviable on 400 mM NaCl NGM plates
Immunohistochemistry. Polyclonal antisera speciﬁc to OSM-11
were raised in rabbits using the C-terminal peptide YSKCTMFTPV-
QY (Sigma-Genosys) and was used as a 1:200 dilution of unpuriﬁed
sera. OSM-11 immunoreactivity was detected in larval and adult
animals in paraformaldehyde-ﬁxed wild-type animals, but not in osm-
11(rt142lf) animals (unpublished data). Eggs were not examined, and
no immunoreactivity in germ cells was observed. OSM-11 was
detected at the junction of the presumptive vulva and uterus of L4
larvae and in the spermatheca of late-larval and adult animals. OSM-
11 mRNA localization by in situ hybridization is consistent with
expression in VPCs and hypoderm in young larvae and in seam cells
in adult animals (see NEXTDB, http://nematode.lab.nig.ac.jp/db2/
ShowCloneInfo.php?clone¼59g10; Y. Kohara, personal correspond-
ence).
Molecular biology. Plasmids and cloning details are available upon
request. Transgenic strains were generated by microinjection with
plasmids of interest at 20 to 50 ng/ll. Transgenesis coinjection
markers were pJM#67 elt-2::gfp [91], pPD48.33 myo-2::gfp [92], or
phenotypic rescue of pha-1(e2123) using pBX#1 [93]. The osm-11 cDNA
clone was obtained by PCR from the Vidal laboratory ORFeome
cDNA library [94] and agrees exactly with the predicted sequence in
WormBase and at NCBI. osm-11 cDNA constructs used herein for
rescue contained the unc-54 39 UTR, whereas genomic rescue clones
contained the osm-11 39 UTR. Although osm-11 vulval defects are
substantially rescued by both types of constructs, we cannot rule out
transcriptional regulation by the osm-11 39 UTR. Multiple transgenic
lines were scored for each transgenic experiment; results were
substantially equal for each transgenic line and were pooled by
construct. The soluble lag-2 construct was previously described and
fully rescues a lag-2 mutant [23]. Mammalian DLK1 has multiple splice
forms yielding soluble and membrane-bound isoforms. Proteolysis of
membrane-bound DLK1 yields the soluble protein originally known
as fetal antigen 1 (FA1). A murine DLK1 cDNA fragment that encodes
the DLK1 FA1 protein isoform was used in C. elegans rescue
experiments and was expressed ubiquitously using the hsp-16
promoter.
Bioinformatics. C. elegans and C. briggsae homologs of OSM-11 were
identiﬁed by BLAST analysis against genomic sequences and
predicted genes at NCBI and WormBase. A short, common motif
was identiﬁed manually and used to search for similar proteins using
Pattern Search at the Swiss Institute for Experimental Cancer
Research (ISREC) (http://myhits.isb-sib.ch/cgi-bin/pattern_search). A
subset of Notch ligands was identiﬁed. DLK1 and Drosophila Delta
proteins were manually compared to C. elegans and C. briggsae
homologs of OSM-11 and used to generate the ﬁnal DOS-motif
consensus (Figure 2). Proteins were aligned using ClustalW at ISREC
(http://myhits.isb-sib.ch/cgi-bin/clustalw). The proteins identiﬁed are
known Notch ligands except for mouse DLK1, Drosophila C901, and
human EGFL9. Drosophila C901 contains a signal peptide, a DSL
domain, and EGF repeats, but has not been well characterized [56].
DLK1 and EGFL9 do not contain DSL domains, but do contain signal
peptides and EGF repeats. Given that all previously identiﬁed DSL
domains are located between the signal peptide sequence and the
EGF repeats, we conclude that DLK1 and EGFL9 do not contain DSL
domains. It is interesting to note that many classical Notch ligand
genes contain an intron immediately after the DSL domain.
T05D4.4 and ZK507.4 (OSM-7 and DOS-1, respectively) predicted
C. elegans proteins are partially conﬁrmed by existing cDNAs and are
conserved in C. briggsae. A cDNA fragment containing predicted C.
elegans K10G6.2 (dos-2) exons was successfully ampliﬁed from a cDNA
library by the Vidal ORFeome project; the K10G6.2 predicted protein
is also conserved in C. briggsae. The C. briggsae homologs of C. elegans
proteins are CBG18238 for T05D4.4, CBG18440 for K10G6.2,
CBG06935 for ZK507.4, and CBG15929 for F11C7.5. The new
prediction for K02F3.7/DOS-3 has been submitted to WormBase;
the C. briggsae homolog is CBP19746. All of these C. briggsae proteins
are predicted to have signal peptide sequences. Proteins in D.
melanogaster, C. elegans, C. briggsae, Homo sapiens, Danio rerio, and Mus
musculus that contain the DOS motif are (amino acids): tr:A1L1P2_-
DANRE/224–274, tr:A1C3M9_DANRE/228–278, sw:DLL1_HUMAN/
226–276, sw:DLL1_MOUSE/225–275, tr:A4V346_DROME/231–279,
sw:DLLB_DANRE/208–258, tr:Q9VZ44_DROME/212–262,
tr:Q925U3_MOUSE/26–76, NP_003827/26–76, sw:EGFL9_HU-
MAN/29–79, sw:Q8K1E3 EGFL9/29–79, tr:A1A3Y8_DANRE/235–
285, tr:A1A3Y7_DANRE/231–281, sw:JAG1_HUMAN/234–284,
sw:JAG1_MOUSE/234–284, sw:JAG2_MOUSE/245–295, sw:JA-
G2_HUMAN/245–295, tr:Q90Y55_DANRE/237–287, sw:SERR_-
DROME/284–335, tr:O45750_CAEEL/205–253, tr:Q60YH7_CAEBR/
205–253, tr:Q21149_CAEEL/127–175, tr:Q60JE9_CAEBR/385–433,
sw:YOO4_CAEEL/130–179, tr:Q614N0_CAEBR/135–180,
tr:O45346_CAEEL/136–181, and tr:Q60Y06_CAEBR/130–177.
DOS-motif proteins were clustered using CLUSTALW in the
MegAlign package (Lasergene) with an identity matrix and the
following default parameters: gap penalty 20.0, gap length penalty 0.2,
delay divergent sequences 30%, and DNA transition weight 0.5. The
N- and C-terminal boundaries of the amino acid sequences used for
the alignment began at the ﬁrst cysteine residue of the ﬁrst EGF
repeat, and ended at the cysteine residue immediately preceding the
conserved CXC motif of the second EGF repeat. The only exceptions
to this were the sequences used for MmJagged1 and HsJagged1; in
these proteins, a gap between EGF repeats 1 and 2 contained cysteine
and tryptophan residues that followed the spacing of the DOS motif
consensus sequence but were clearly not part of EGF repeat 2. Amino
acid sequence from the gap instead of from EGF repeat 2 was used for
these two proteins. Two outgroups were used in the alignment: EGF
repeats 1 and 2 from CeAPX-1 and CeLAG-2, which lack the SELCT
motif and have been previously shown to be phylogenetically distinct
from EGF repeats 1 and 2 of other DSL ligands [27]; and EGF repeats
3 and 4 (EGF3–4) of selected DOS motif–containing proteins (using
the same N- and C-terminal boundaries as above), as examples of
canonical EGF repeats. DmSerrate EGF repeat 4 contains a
phylogenetically unique insertion; for the purposes of sequence
alignment, amino acids 407–470 were deleted [27]. Accession
numbers used are: CeT05D4.4, O45750; Cezk507.4, P34636; CeSEL-
14, O45346; CeK10G6.2, O16627; CeAPX-1, P41990; CeLAG-2, P45442;
DrDeltaA, AAC41249; DrDeltaB, AAH76414; DrDeltaD, Q8UWJ4;
DrJagged1, Q90Y57; DrJagged2, CAH69088; DrSerrateB, AAC98354;
DmDelta, P10041; DmSerrate, P18168; DmC901, CAA72010; HsDll1,
O00548; HsEgﬂ9, Q6UY11; HsJagged1, P78504; HsJagged2, Q9Y219;
MmDlk1, NP_034182; MmDll1, Q61483; MmJagged1, Q9QXX0; and
MmJagged2, Q9QYE5. Species designations are: Ce, Caenorhabditis
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OSM-11 and LIN-12 Notch in Developmentelegans; Dr, Danio rerio; Dm, Drosophila melanogaster; Hs, Homo sapiens;
Mm, Mus musculus.
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